NutriBand (NTRB) Revenue (2018 - 2026)
NutriBand (NTRB) posted Revenue of $433399.0 for Q2 2026, up 8.16% sequentially from $400709.0 in Q1 2026, and down 35.06% YoY from $667432.0 in Q2 2025.
NutriBand (NTRB) Revenue (2018 - 2026) Analysis & Trends
NutriBand has reported Revenue for 9 years, with the latest figure at $433399.0 in Q2 2026.
- Quarterly Revenue fell 35.06% year-over-year to $433399.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $1.8 million (down 24.84% YoY) and the FY2026 annual result came in at $2.0 million, down 4.81% from the prior year.
- Revenue improved to $433399.0 in Q2 2026 per NTRB's latest filing, from $400709.0 in the prior quarter.
- Over five years, Revenue peaked at $667432.0 in Q2 2025 and troughed at $346058.0 in Q4 2025.
- A 5-year average of $514800.0 and a median of $484906.0 in 2022 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2025: Revenue surged 246.63% in 2022, then slumped 46.41% in 2025.
- Over 5 years, Revenue stood at $618003.0 in 2022, then slumped by 30.77% to $427841.0 in 2023, then surged by 50.94% to $645796.0 in 2024, then plunged by 46.41% to $346058.0 in 2025, then rose by 25.24% to $433399.0 in 2026.
- According to Business Quant data, Revenue over the past three periods registered $433399.0, $400709.0, and $346058.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | NutriBand | 46.38 Mn | 42.37 Mn | 196,801.00 | 433,399.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 433,399.00 |
| Jan 31, 2026 | 400,709.00 |
| Oct 31, 2025 | 346,058.00 |
| Jul 31, 2025 | 622,452.00 |
| Apr 30, 2025 | 667,432.00 |
| Jan 31, 2025 | 642,379.00 |
| Oct 31, 2024 | 645,796.00 |
| Jul 31, 2024 | 442,830.00 |
| Apr 30, 2024 | 408,532.00 |
| Jan 31, 2024 | 524,613.00 |
| Oct 31, 2023 | 427,841.00 |
| Jul 31, 2023 | 655,928.00 |
| Apr 30, 2023 | 476,932.00 |
| Jan 31, 2023 | 527,535.00 |
| Oct 31, 2022 | 618,003.00 |
| Jul 31, 2022 | 456,149.00 |
| Apr 30, 2022 | 477,922.00 |
| Jan 31, 2022 | 491,890.00 |
| Oct 31, 2021 | 283,037.00 |
| Jul 31, 2021 | 213,739.00 |